Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Cilostazol on the Clinical Outcome of Patients with Parkinson's Disease

NCT06612593 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT06612593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06612593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Cilostazol on the Clinical Outcome of Patients with Parkinson's Disease
Lead sponsor
Ain Shams University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 1, 2024
Completion date
October 1, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease